Randolph Floyd, Chief Executive Officer, is a business executive with over 30 years of experience in product development and operations management. At Merck & Co. he was Vice President, Project Planning and Development at the company’s Medco unit, overseeing the unit’s new product development portfolio. In Merck’s core pharmaceutical business, he led a variety of complex global initiatives. For eleven years he has served as a business operations and restructuring expert at AlixPartners, a global consultancy. He earned MBA and AB (chemistry) degrees from the University of Chicago.
David Kaplan MD, PhD, Chief Scientific Officer and the inventor of CellPrint™ technology. He has been a professor of pathology at Case Western Reserve University and served as the director of diagnostic immunology for University Hospitals Case Medical Center. David has published over 70 manuscripts in journals including Science, Proceedings of the National Academy of Sciences, Blood, FASEB Journal, Journal of Experimental Medicine, Journal of Immunology, Journal of Virology, and Cancer Research. He has chaired review committees for NIH and the American Cancer Society and served on the editorial board of several scientific journals. David earned MD and PhD degrees from the University of Chicago and served as a postdoctoral fellow at Washington University.